Cat-allergen intralymphatic immunotherapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Cat-allergen intralymphatic immunotherapy, covering 2026-03-16 to 2026-03-16. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Immunogenicity of Cat-allergen Intralymphatic Immunotherapy in Patients With Cat Allergy With and Without Asthma [Phase 1, Phase 2]